NYSE:MDCM.D.C. Stock Price, Forecast & News

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MDC stock has increased by 9.5% and is now trading at $37.19. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 4 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for M.D.C..

M.D.C. is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for M.D.C..

M.D.C. will be holding an earnings conference call on Tuesday, July 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

M.D.C. Holdings, Inc. (NYSE:MDC) issued its earnings results on Tuesday, May, 5th. The construction company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.69 by $0.13. The construction company earned $697.10 million during the quarter, compared to analyst estimates of $733.88 million. M.D.C. had a net margin of 7.01% and a return on equity of 13.48%. M.D.C.'s revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.64 earnings per share. View M.D.C.'s earnings history.

M.D.C. declared a quarterly dividend on Friday, April 3rd. Shareholders of record on Wednesday, May 6th will be given a dividend of $0.33 per share on Wednesday, May 20th. This represents a $1.32 annualized dividend and a dividend yield of 3.55%. The ex-dividend date of this dividend is Tuesday, May 5th. View M.D.C.'s dividend history.

7 Wall Street analysts have issued 12 month price targets for M.D.C.'s shares. Their forecasts range from $22.00 to $42.00. On average, they expect M.D.C.'s stock price to reach $32.00 in the next year. This suggests that the stock has a possible downside of 14.0%. View analysts' price targets for M.D.C..

Headlines about MDC stock have been trending neutral on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. M.D.C. earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave news stories about the construction company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about M.D.C..

M.D.C. saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,230,000 shares, an increase of 7.9% from the May 31st total of 1,140,000 shares. Based on an average daily trading volume, of 740,500 shares, the days-to-cover ratio is presently 1.7 days. Approximately 2.5% of the shares of the stock are sold short. View M.D.C.'s Current Options Chain.

Some companies that are related to M.D.C. include D. R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), Meritage Homes (MTH), KB Home (KBH), TRI Pointe Group (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH) and Hovnanian Enterprises (HOV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Verizon Communications (VZ), NVIDIA (NVDA), Intel (INTC), CVS Health (CVS), Walt Disney (DIS), AT&T (T) and Procter & Gamble (PG).

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C.'s stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.07%), 6 Meridian (0.01%) and Carroll Financial Associates Inc. (0.00%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View institutional ownership trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including 6 Meridian, and Carroll Financial Associates Inc.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, and Raymond T Baker. View insider buying and selling activity for M.D.C..

MDC stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. View insider buying and selling activity for M.D.C..

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MDC stock can currently be purchased for approximately $37.19.

M.D.C. has a market capitalization of $2.34 billion and generates $3.29 billion in revenue each year. The construction company earns $238.31 million in net income (profit) each year or $3.72 on an earnings per share basis. M.D.C. employs 1,656 workers across the globe.

The official website for M.D.C. is www.mdcholdings.com.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]